An NP is treating a patient with Parkinsonian symptoms and wants to target the nigrostriatal tract to improve extrapyramidal function. What is the expected outcome of increasing dopamine in the nigrostriatal tract?
- Improvement in Parkinsonian symptoms
- Improvement in negative symptoms of psychiatric disease
- Reduction in hallucinations and delusions
- Increase in prolactin levels
- Increase in nausea and vomiting